Search For a Provider Facebook Twitter Instagram YouTube ES View the Patient Toolkit


Prescriptions Too Costly for Many Cancer Survivors

Prescriptions Too Costly for Many Cancer SurvivorsCancer survivors in the United States are more likely to leave their prescriptions unfilled than those without cancer, new research shows.

The main reason? Cost.

“Spending on prescription drugs to treat cancer has been increasing in the United States, and many newer cancer drugs have annual price tags of $100,000 or more,” K. Robin Yabroff of the National Cancer Institute told Reuters Health.

Dr. Yabroff co-authored a study on the subject that was published in August in the Journal of the National Cancer Institute.

The research team looked at data from the 2010-2015 National Health Interview Survey and determined the rates of limited prescription drug access in the U.S.

Overall, these rates decreased during the time period studied.

1 2 3 Next » (page 1 of 3)